Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Anti-CCP versus anti-Sa antibodies for the diagnosis of RA

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Dejaco C et al. (2006) Diagnostic value of antibodies against a modified citrullinated vimentin in RA. Arthritis Res Ther 19: R119

    Article  Google Scholar 

  2. Ménard HA et al. (2000) Insights into RA derived from the Sa immune system. Arthritis Res Ther 2: 429–432

    Article  Google Scholar 

  3. Boire G et al. (2005) Anti-Sa antibodies and antibodies against CCP are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis. Arthritis Res Ther 7: R592–603

    Article  CAS  Google Scholar 

  4. Asaga H et al. (1998) Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages. Biochem Biophys Res Commun 243: 641–646

    Article  CAS  Google Scholar 

  5. Hill JS et al. (2003) Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 171: 538–541

    Article  CAS  Google Scholar 

  6. Auger I et al. (2005) Influence of HLA-DR genes on the production of RA-specific autoantibodies to citrullinated fibrinogen. Arthritis Rheum 52: 3424–3432

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ménard, H. Anti-CCP versus anti-Sa antibodies for the diagnosis of RA. Nat Rev Rheumatol 3, 76–77 (2007). https://doi.org/10.1038/ncprheum0401

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0401

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing